Literature DB >> 28512794

Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report.

Catia Marzolini1, Laurent Decosterd2, Ursula Winterfeld3, Frédéric Tissot4, Katyuska Francini5, Thierry Buclin3, Françoise Livio3.   

Abstract

Entities:  

Keywords:  cobicistat; elvitegravir; free concentrations; pharmacokinetics; pregnancy; total concentrations

Mesh：

Substances：

Year:  2017        PMID： 28512794      PMCID： PMC5698588          DOI： 10.1111/bcp.13310

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fraction.

Authors:  Aurélie Fayet; Alexandre Béguin; Begona Martinez de Tejada; Sara Colombo; Matthias Cavassini; Stefan Gerber; Chin B Eap; Amalio Telenti; Thierry Buclin; Jérôme Biollaz; Laurent A Decosterd
Journal:  Ther Drug Monit       Date:  2008-08       Impact factor: 3.681

2.  Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report.

Authors:  Catia Marzolini; Laurent Decosterd; Ursula Winterfeld; Frédéric Tissot; Katyuska Francini; Thierry Buclin; Françoise Livio
Journal:  Br J Clin Pharmacol       Date:  2017-05-16       Impact factor: 4.335

3.  First reported use of elvitegravir and cobicistat during pregnancy.

Authors:  Stein Schalkwijk; Angela Colbers; Deborah Konopnicki; Rick Greupink; Frans G M Russel; David Burger
Journal:  AIDS       Date:  2016-03-13       Impact factor: 4.177

4.  Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein.

Authors:  Huixiao Hong; William S Branham; Hui Wen Ng; Carrie L Moland; Stacey L Dial; Hong Fang; Roger Perkins; Daniel Sheehan; Weida Tong
Journal:  Toxicol Sci       Date:  2014-10-27       Impact factor: 4.849

5.  Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics.

Authors:  F T Aweeka; C Hu; L Huang; B M Best; A Stek; P Lizak; S K Burchett; J S Read; H Watts; M Mirochnick; E V Capparelli
Journal:  HIV Med       Date:  2014-11-18       Impact factor: 3.180

6.  Quantification of neurosteroids during pregnancy using selective ion monitoring mass spectrometry.

Authors:  Kurt D Pennell; Mark A Woodin; Page B Pennell
Journal:  Steroids       Date:  2014-12-23       Impact factor: 2.668

7.  A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients.

Authors:  Manel Aouri; Alexandra Calmy; Bernard Hirschel; Amalio Telenti; Thierry Buclin; Matthias Cavassini; Andri Rauch; Laurent A Decosterd
Journal:  J Mass Spectrom       Date:  2013-05       Impact factor: 1.982

8.  Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals.

Authors:  Catalina Barceló; Frédéric Gaspar; Manel Aouri; Alice Panchaud; Margalida Rotger; Monia Guidi; Matthias Cavassini; Thierry Buclin; Laurent A Decosterd; Chantal Csajka
Journal:  J Antimicrob Chemother       Date:  2016-03-29       Impact factor: 5.790

Review 9.  Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors.

Authors:  Anthony T Podany; Kimberly K Scarsi; Courtney V Fletcher
Journal:  Clin Pharmacokinet       Date:  2017-01       Impact factor: 6.447

10.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands.

Authors:  Christopher Southan; Joanna L Sharman; Helen E Benson; Elena Faccenda; Adam J Pawson; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Michael Spedding; William A Catterall; Doriano Fabbro; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2015-10-12       Impact factor: 16.971
View more
  7 in total

1.  Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report.

Authors:  Catia Marzolini; Laurent Decosterd; Ursula Winterfeld; Frédéric Tissot; Katyuska Francini; Thierry Buclin; Françoise Livio
Journal:  Br J Clin Pharmacol       Date:  2017-05-16       Impact factor: 4.335

2.  Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV.

Authors:  Jeremiah D Momper; Brookie M Best; Jiajia Wang; Edmund V Capparelli; Alice Stek; Emily Barr; Martina L Badell; Edward P Acosta; Murli Purswani; Elizabeth Smith; Nahida Chakhtoura; Kyunghun Park; Sandra Burchett; David E Shapiro; Mark Mirochnick
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

Review 3.  Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy.

Authors:  Engie Salama; Ahizechukwu C Eke; Brookie M Best; Mark Mirochnick; Jeremiah D Momper
Journal:  J Clin Pharmacol       Date:  2020-08-14       Impact factor: 3.126

4.  Free dug concentrations in pregnancy: Bound to measure unbound?

Authors:  Stein Schalkwijk; Rick Greupink; David Burger
Journal:  Br J Clin Pharmacol       Date:  2017-10-06       Impact factor: 4.335

Review 5.  Drug-Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?

Authors:  Vera E Bukkems; Angela Colbers; Catia Marzolini; Jose Molto; David M Burger
Journal:  Clin Pharmacokinet       Date:  2020-10       Impact factor: 6.447

6.  Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.

Authors:  L Ryom; C Boesecke; M Bracchi; J Ambrosioni; A Pozniak; J Arribas; G Behrens; Pgm Mallon; M Puoti; A Rauch; J M Miro; O Kirk; C Marzolini; J D Lundgren; M Battegay
Journal:  HIV Med       Date:  2018-03-01       Impact factor: 3.180

Review 7.  Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge Gaps.

Authors:  Ruben van der Galiën; Rob Ter Heine; Rick Greupink; Stein J Schalkwijk; Antonius E van Herwaarden; Angela Colbers; David M Burger
Journal:  Clin Pharmacokinet       Date:  2019-03       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.